iScience (Jun 2021)

SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis

  • Sabina Sangaletti,
  • Laura Botti,
  • Alessandro Gulino,
  • Daniele Lecis,
  • Barbara Bassani,
  • Paola Portararo,
  • Matteo Milani,
  • Valeria Cancila,
  • Loris De Cecco,
  • Matteo Dugo,
  • Claudio Tripodo,
  • Mario P. Colombo

Journal volume & issue
Vol. 24, no. 6
p. 102510

Abstract

Read online

Summary: The secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein with unexpected immunosuppressive function in myeloid cells. We investigated the role of SPARC in autoimmunity using the pristane-induced model of lupus that, in mice, mimics human systemic lupus erythematosus (SLE). Sparc−/− mice developed earlier and more severe renal disease, multi-organ parenchymal damage, and arthritis than the wild-type counterpart. Sparc+/- heterozygous mice showed an intermediate phenotype suggesting Sparc gene dosage in autoimmune-related events. Mechanistically, reduced Sparc expression in neutrophils blocks their clearance by macrophages, through defective delivery of don't-eat-me signals. Dying Sparc−/− neutrophils that escape macrophage scavenging become source of autoantigens for dendritic cell presentation and are a direct stimulation for γδT cells. Gene profile analysis of knee synovial biopsies from SLE-associated arthritis showed an inverse correlation between SPARC and key autoimmune genes. These results point to SPARC down-regulation as a leading event characterizing SLE and rheumatoid arthritis pathogenesis.

Keywords